By reviewing the data and tweets, can we predict if the closing price of $bmy will go upwards or downwards at 2017-06-19? Please indicate either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-06-05,2.7,3.8,-0.3,-4.7,-4.7,3.0,3.2,3.4,3.8,4.3,4.3
2017-06-06,1.2,1.4,-0.1,-1.3,-1.3,3.6,4.1,4.3,4.9,5.3,5.6
2017-06-07,-1.4,0.0,-1.9,1.8,1.8,1.2,2.0,2.3,2.9,3.3,3.7
2017-06-08,-0.5,1.0,-0.6,0.5,0.5,0.1,1.3,1.6,2.1,2.5,3.1
2017-06-09,-1.8,0.8,-2.0,1.7,1.7,-2.1,-0.6,-0.1,0.3,0.7,1.2
2017-06-12,-1.1,0.0,-1.6,1.1,1.1,-2.4,-1.6,-1.2,-0.9,-0.5,-0.0
2017-06-13,0.0,0.2,-0.5,-0.3,-0.3,-1.2,-1.2,-0.9,-0.7,-0.2,0.2
2017-06-14,-0.5,0.5,-0.7,0.6,0.6,-1.1,-1.7,-1.5,-1.3,-0.9,-0.5
2017-06-15,0.4,0.8,-0.5,-0.4,-0.4,-0.1,-1.3,-1.0,-0.9,-0.5,-0.1
2017-06-16,0.1,0.3,-1.6,0.3,0.3,-0.2,-1.8,-1.3,-1.1,-0.9,-0.5

2017-06-05: bristol-myers squibb's opdivo, yervoy put the brakes on mesothelioma in phase 2  $bmy #asco17|tuesday: $tho, $acor, $rh, $tsla, $panw, $vmw, $bmy|rt AT_USER on the fly: top stock stories at midday $aa
2017-06-06: rt AT_USER bms' opdivo, merck's keytruda lead their class in cancer vaccine combo studies: report  $bmy $mrk|rt AT_USER they key on the $bmy lag3 data is the high lag3 expressers. 5 of 6 responses in 
2017-06-07: rt AT_USER with asco data tallied, bristol-myers loses ground to merck in i-o field  $bmy $mrk|current positions in the live mentorship program options trading account. $cmcsa $tsla $pypl $bx $jnj $bm
2017-06-08: rt AT_USER bristol myers $bmy iv rallied late day with 3,000 december $60 calls bought to open $0.95, opening put seller june 2018 to¡­|$bmy is in stochastic oversold  winning 61.40% in the past. |#br
2017-06-09: rt AT_USER AT_USER AT_USER $kite $juno $amgn $nvs $bmy $mrk #dcvax will disrupt all. $nwbo $blue $celg $sgen $loxo #pem¡­|rt AT_USER AT_USER AT_USER $kite $juno $amgn $nvs $bmy $mrk #dcvax will disrup
2017-06-10: bristol-myers squibb co $bmy stock rating upgraded by bidaskclub |bristol-myers squibb co $bmy raised to hold at bidaskclub |bristol-myers squibb co $bmy upgraded to hold by bidaskclub  #stocks|bristo
2017-06-11: rt AT_USER the $bmy cancer yo-yo, and a setback that leaves it vulnerable to takeover talk. by AT_USER  v¡­|$ibb stong most of the day, closed weak, still watching for roation. select names have been 
2017-06-12: rt AT_USER the $bmy cancer yo-yo, and a setback that leaves it vulnerable to takeover talk. by AT_USER  v¡­|#bristolmyerssquibb novartis in new deal on opdivo combinations. read more:  $bmy|#bristolmy
2017-06-13: dow jones analysis video - $djia $dia $sdow  $xom $ge $gs $mrk $pfe $bmy $vz  #stockmarket #stocks #trading #dowjones|dow jones analysis video - $djia $dia $sdow  $xom $ge $gs $mrk $pfe $bmy $vz  #sto
2017-06-14: salphatrending: bristol-myers squibb's (bmy) management presents at goldman sachs 38th annual global health...  $bmy|bristol-myers squibb's (bmy) management presents at goldman sachs 38th annual globa
2017-06-15: ltm ebitda multiple of gilead sciences, inc. $gild is currently below all peers: $abbv $bmy $lly $mrk $pfe¡­ |$bmy then bear pattern is not confirmed. a new bear pattern is detected.|AT_USER seeing a 
2017-06-16: 6 reasons why prescription drug prices are extremely expensive AT_USER #stocks $pfe, $bmrn, $bmy, $lly, $abbv |$myo regardless they going to get bought out hearing they have a very impressive board. m
2017-06-17: abbvie $abbv ltm ebitda multiple trading below majority of peers: $bmy $lly $mrk $pfe $amgn  |if your a #dad #mom #child you deserve better tratments for #cancer exciting times ahead $nwbo $kite $bmy 
2017-06-18: final read out coming soon $nwbo #dcvax-l just the beginning. $kite and others like $juno $bmy $agio $fgen doing am¡­ 
Answer:
Rise